{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:43:15Z","timestamp":1790685795823,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaad.2018.02.053","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T17:48:50Z","timestamp":1519926530000},"page":"495-500.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States"],"prefix":"10.1016","volume":"79","author":[{"given":"Amit","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Papagermanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretta","family":"Midura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Merson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.02.053_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice: hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.02.053_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.det.2015.07.003","article-title":"The handicap of hidradenitis suppurativa","volume":"34","author":"Deckers","year":"2016","journal-title":"Dermatol Clin"},{"issue":"5 suppl 1","key":"10.1016\/j.jaad.2018.02.053_bib3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jaad.2015.07.054","article-title":"The psychosocial impact of hidradenitis suppurativa","volume":"73","author":"Gooderham","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib4","unstructured":"Explorys Inc. Available at: https:\/\/public.dhe.ibm.com\/common\/ssi\/ecm\/hp\/en\/hps03052usen\/HPS03052USEN.PDF. Accessed November 30, 2017."},{"key":"10.1016\/j.jaad.2018.02.053_bib5","unstructured":"U.S. National Library of Medicine Unified Medical Language System (UMLS): Systematized Nomenclature of Medicine\u2014ClinicalsTerms (SNOMED CT). Available at: http:\/\/www.nlm.nih.gov\/research\/umls\/Snomed\/snomed_main.html. Accessed November 30, 2017."},{"key":"10.1016\/j.jaad.2018.02.053_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: RxNorm at 6 years","volume":"18","author":"Nelson","year":"2011","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jaad.2018.02.053_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1373\/49.4.624","article-title":"LOINC, a universal standard for identifying laboratory observations: a 5-year update","volume":"49","author":"McDonald","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaad.2018.02.053_bib8","first-page":"711","article-title":"An exploration of the complex relationship of socioecologic factors in the treatment and outcomes of acute myocardial infarction in disadvantaged populations","volume":"36","author":"Shen","year":"2001","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jaad.2018.02.053_bib9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/1471-2458-10-632","article-title":"Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance","volume":"10","author":"Foraker","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jaad.2018.02.053_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000468148","article-title":"Validation of a case finding algorithm for hidradenitis suppurativa using administrative coding from a clinical database","volume":"233","author":"Strunk","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2018.02.053_bib11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2011.11.948","article-title":"Risks of developing psychiatric disorders in pediatric patients with psoriasis","volume":"67","author":"Kimball","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib15","doi-asserted-by":"crossref","first-page":"e0176416","DOI":"10.1371\/journal.pone.0176416","article-title":"Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: a cross-sectional study","volume":"12","author":"Adejumo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2018.02.053_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jsat.2017.02.007","article-title":"Costs of substance use disorders from claims data for Medicare recipients from a population-based sample","volume":"77","author":"Fairman","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jaad.2018.02.053_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/15360288.2016.1231739","article-title":"Prevalence of prescription opioid misuse\/abuse as determined by International Classification of Diseases codes: a systematic review","volume":"30","author":"Roland","year":"2016","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jaad.2018.02.053_bib18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1185\/03007995.2014.915803","article-title":"Use of prescription opioids with abuse-deterrent technology to address opioid abuse","volume":"30","author":"Michna","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2018.02.053_bib19","first-page":"718","article-title":"Burden of alcohol abuse or dependence among long-term opioid users with chronic noncancer pain","volume":"23","author":"Landsman-Blumberg","year":"2017","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jaad.2018.02.053_bib20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/bjd.14976","article-title":"High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics","volume":"176","author":"Desai","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib21","series-title":"Global status report on alcohol and health\u20142014","year":"2014"},{"key":"10.1016\/j.jaad.2018.02.053_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths \u2014 United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaad.2018.02.053_bib23","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJMsr1601307","article-title":"A proactive response to prescription opioid abuse","volume":"374","author":"Califf","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.02.053_bib24","unstructured":"National Institute on Drug Abuse website. Nationwide trends: National Survey on Drug Use and Health. Available at: https:\/\/www.drugabuse.gov\/publications\/drugfacts\/nationwide-trends. Accessed November 26, 2017."},{"key":"10.1016\/j.jaad.2018.02.053_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib28","first-page":"446","article-title":"Kwaliteit van leven bij Nederlandse pati\u00ebnten met hidradenitis suppurativa (acne inversa) [English abstract]","volume":"19","author":"Benjamins","year":"2009","journal-title":"Ned Tijdschr Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.02.053_bib29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","article-title":"Hidradenitis suppurativa markedly decreases quality of life and professional activity","volume":"62","author":"Matusiak","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.02.053_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.02.053_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.02.053_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40257-014-0105-5","article-title":"Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study","volume":"16","author":"Alavi","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2230.1996.tb00145.x","article-title":"Hidradenitis suppurativa\u2014characteristics and consequences","volume":"21","author":"Jemec","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2018.02.053_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09546634.2017.1341614","article-title":"Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa","volume":"29","author":"Kimball","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2018.02.053_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200202213460825","article-title":"Medicaid","volume":"346","author":"Rosenbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.02.053_bib38","unstructured":"Ku L. MEDICAID: improving health, saving lives. Available at: https:\/\/www.cbpp.org\/archives\/7-19-05health.htm. Washington, DC: Center on Budget and Policy Priorities; 2005."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218303384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218303384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:46:53Z","timestamp":1759272413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218303384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0190962218303384"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.02.053","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.02.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}